NCT01979874View on ClinicalTrials.gov

The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Peripheral Arterial Disease
Interventions
DIETARY_SUPPLEMENT

Pro-Omega

Pro-Omega (Nordic Naturals, Watsonville, CA, USA). Each ProOmega capsule contains 325mg of EPA and 225mg of DHA. 4.4gm/day x 3 months

OTHER

ProOmega Placebo

Placebo Comparator: soybean (Nordic Naturals, Watsonville, CA, USA); 4.4gm/day x 3 months

Trial Locations (1)

94121

San Francisco Veterans Affairs Medical Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01979874 - The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II | Biotech Hunter | Biotech Hunter